Press Release

30 Apr 25

Plant Advanced Technologies Releases 2024 Annual Results

Vandoeuvre lès Nancy, France – Apr 29 2025 – 2024 annual results:  • First positive operating profit since PAT’s creation in 2005: €215,000 compared to a loss of €778,000 in 2023• Strong increase in net profit to €935,000 (48% of revenue) compared to €79,000 in 2023• Outlook: Confirmation of the…
Read More
17 Apr 25

IRIS Capital invests in SYNBIOTIC’s growth strategy

Düsseldorf, Germany– apr  17, 2025  – The European medical cannabis and industrial hemp group SYNBIOTIC SE  and the venture capital company IRIS Capital Investment have entered into a strategic partnership. The French investment company will actively support SYNBIOTIC’s growth strategy. In a first phase, IRIS Capital Investment has decided and…
Read More
17 Dec 24

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE AN AGREEMENT LICENSE FOR THE MARKETING OF THERANEXUS TX01 IN THE TREATMENT OF TWO RARE NEUROLOGICAL DISEASES

Lyon, France, dec 17, 2024  – Theranexus, an innovative biopharmaceutical company specializing in the treatment of rare neurological diseases, and Exeltis, a global pharmaceutical company of the Insud Pharma group, announce the signing of a licensing and distribution agreement for the commercialization of Theranexus’ TX01, a new formulation of a…
Read More